Sign in

CIK 0001267565

  • Large accelerated filer

COLLEGIUM PHARMACEUTICAL, INC

Sign in to watch
Ticker
COLL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
Phone
+1 781-713-3699
Business address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
Former names
COLLEGIUM PHARMACEUTICAL INC
  1. 4 Grant or award Director acquired 4,707 shares (grant or award)
  2. 4 Grant or award Director acquired 4,707 shares (grant or award)
  3. 4 Grant or award Director acquired 4,707 shares (grant or award)
  4. 4 Grant or award Director acquired 4,707 shares (grant or award)
  5. 4 Grant or award Director acquired 4,707 shares (grant or award)
  6. 4 Open-market sale Director sold 25,000 shares at an average $15.09 ($377,366)
  7. 4 Grant or award EVP and Chief Medical Officer acquired 42,500 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes EVP and General Counsel gave up 1,470 shares (to pay taxes)
  10. 4 Open-market sale Director sold 25,000 shares at $17.17 ($429,250)
  11. 4 Open-market sale Director sold 25,000 shares at an average $14.81 ($370,224)
  12. 4 Shares withheld for taxes Director gave up 7,851 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Technology Officer gave up 2,714 shares (to pay taxes)
  14. 4 Shares withheld for taxes President and CEO gave up 2,052 shares (to pay taxes)
  15. 4 Shares withheld for taxes Executive Vice President & CFO gave up 2,693 shares (to pay taxes)
  16. 4 Grant or award EVP & Chief Commercial Officer acquired 25,600 shares (grant or award)
  17. 4 Grant or award Chief Technology Officer acquired 25,600 shares (grant or award)
  18. 4 Grant or award Executive Vice President & CFO acquired 32,000 shares (grant or award)
  19. 4 Grant or award EVP and General Counsel acquired 25,600 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 90,000 shares (grant or award)

Page 14 of 21 · 415 filings